Immunogenicity of Two Dosages of Inactivated, Split-Virion Influenza Vaccine Given by an Alternate Route in the Elderly

Clinical trial NCT00296829 · COMPLETED

Trial details

NCT number: NCT00296829
Sponsor: Sanofi Pasteur, a Sanofi Company
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Orthomyxoviridae Infection Influenza Myxovirus Infection

Start date: 2006-01-01
Primary completion: 2007-02-01
Enrollment: 1080

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.